In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

View Content for:
Display:
  •          
Help with display options.
Results 1-8 of 8 for your search:
Drug:  recombinant CD40-ligand
Find trials that include:  Any drugs shown
Trial Status:  Closed
Start Over
        Show
1.

Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: Over 18
Sponsor: Other
Protocol IDs: ERLANGEN-1490, EU-20232, NCT00053391

2.

Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: over 18
Sponsor: Other
Protocol IDs: ERLANGEN-ONTAK, EU-20246, NCT00056134

3.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: LAC-USC-10M991, NCI-G00-1837, NCI-T99-0102, NCT00006113, T99-0102

4.

Phase: Phase I
Type: Treatment
Status: Closed
Age: Over 21
Sponsor: NCI
Protocol IDs: UCSD-970976, NCI-G98-1477

5.

Phase: Phase I
Type: Treatment
Status: Completed
Age: 16 and over
Sponsor: NCI
Protocol IDs: NCI-01-C-0121, NCI-1035, NCT00020540, 1035

6.

Phase: Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: CDR0000582397, BCM-H-11541, BCM-CLIMAT, NCT00609076

7.

Phase: Phase I
Type: Treatment
Status: Completed
Age: 75 and under
Sponsor: Other
Protocol IDs: H6408-Leu Leu, NCT00058799

8.

Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: H11967, CLIPA, NCT00078520
New Search